Dr. Philomena F. McAndrew, MD
- Medicare services, 2024
- 6,746
- Medicare patients, 2024
- 703
- Part D claims, 2024
- 741
- Publications
- 3
- Clinical trials
- 5
- Practice address
- 9090 Wilshire Blvd, Beverly Hills, CA 90211
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Cedars-Sinai Tower Hematology and Oncology (Tho) - HOPD
Acute Care Hospital outpatient department · Beverly Hills, California
Find Dr. McAndrew's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Philomena F. McAndrew is a hematologist and oncologist in Beverly Hills, California
Dr. McAndrew practices at Cedars-Sinai Tower Hematology and Oncology (Tho) - HOPD in Beverly Hills, California.
Dr. McAndrew's NPI, 1104822600, was assigned on June 21, 2005. Dr. McAndrew graduated from Perelman School of Medicine - Philadelphia in 1978. Dr. McAndrew holds California license G47403.
- NPI
- 1104822600NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9234100710
- NPI enumeration date
- June 21, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 74
- Medical school graduation
- 1978
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Philomena F. McAndrew practices at Cedars-Sinai Tower Hematology and Oncology (Tho) - HOPD in Beverly Hills, California
Dr. McAndrew's primary practice is Cedars-Sinai Tower Hematology and Oncology (Tho) - HOPD, at 9090 Wilshire Blvd, Beverly Hills, CA 90211.
- Cedars-Sinai Tower Hematology and Oncology (Tho) - HOPD9090 Wilshire Blvd, Beverly Hills, CA 90211
Source: Dmand AI Affiliation Data
Dr. Philomena F. McAndrew is affiliated with 6 sites of care and 1 medical group
Dr. McAndrew's primary practice is Cedars-Sinai Tower Hematology and Oncology (Tho) - HOPD in Beverly Hills, California. Dr. McAndrew is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. McAndrew to 3 more hospitals and 1 group practice or clinic, each named with a free account. Dr. McAndrew's employer is on file too: a hospital.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Philomena F. McAndrew's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McAndrew practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Cedars-Sinai Tower Hematology and Oncology (Tho) - HOPD | Available with a free account |
| +5 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Philomena F. McAndrew is one of 1,502 hematologists and oncologists in California
Hematology and oncology is Dr. McAndrew's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. McAndrew is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. McAndrew's licenses on file in 2 states: California and Pennsylvania.
Specialties and state licenses
- Hematology and oncology, CaliforniaPrimary
- Pennsylvania license
Clinical focus
Dmand AI lists breast cancer, chronic anemia, chronic leukemia, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. McAndrew treats.
Hematologists and oncologists near Dr. McAndrew
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Philomena F. McAndrew billed Medicare for 6,746 services in 2024
CMS data shows 6,746 Medicare services from Dr. McAndrew across 12 procedure codes in 2024, for 703 Medicare patients. Medicare paid $192,315 for them.
Dr. McAndrew's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 4,3002024: 4,1603%
- Office and hospital visits
- 2023: 1,5092024: 1,4424%
- Tests and treatments
- 2023: 5472024: 5382%
- Surgery
- 2023: 3172024: 51763%
- Other services
- 2023: 542024: 8965%
Where Dr. McAndrew's Medicare services took place, 2024
- In an office6,727100%
- In a facility190%
Dr. McAndrew compared with the California median for hematologists and oncologists, 2024
- Dr. McAndrew
- California median
- Medicare services
- 6,746vs 9327.2 times
- Medicare patients
- 703vs 2253.1 times
- Part D claims
- 583vs 39448% above
Medians across 1,367 hematologists and oncologists in California with Dmand AI profiles that report each measure.
Dr. McAndrew's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. McAndrew?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. McAndrew and other hematologists and oncologists in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Philomena F. McAndrew treated 703 Medicare patients in 2024, average age 75
CMS counts 703 Medicare patients who saw Dr. McAndrew in 2024. The largest group is 65 to 74, with 329 patients. 75% of them have cancer, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. McAndrew's median patient age at 72, with 97% women.
Dr. McAndrew's Medicare patients by age, 2024
Chronic conditions among Dr. McAndrew's Medicare patients, 2024
- Cancer75%
- High cholesterol75%
- High blood pressure57%
- Arthritis55%
- Osteoporosis50%
- Ischemic heart disease29%
- Anxiety25%
- Mood disorders23%
Share of Medicare patients with each condition. A patient can have several.
Dr. McAndrew's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women97%
- Men2%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Philomena F. McAndrew wrote 741 Medicare Part D claims in 2024
In 2024, Dr. McAndrew wrote 741 Medicare Part D claims for 185 patients. 70% of them were for generic drugs. CMS names the drug for 583 of them, across 16 drugs with 11 or more claims each, at $2,276,332 in total drug cost. In 2023, CMS named 405 claims across 13 drugs.
Dr. McAndrew's Part D claims by kind of drug, 2024
- Generic515 claims70%
- Brand-name226 claims30%
Dr. McAndrew's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 4052024: 58344%
Drugs named by CMS: 16 in 2024, 13 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Philomena F. McAndrew scored 89 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. McAndrew for performance year 2024, reported as part of a group. Dr. McAndrew accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McAndrew as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. McAndrew's MIPS scores, performance year 2024
- 89of 100Final score
- 84.8of 100Quality
- 99of 100Promoting Interoperability
- 40of 100Improvement Activities
- 73of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Philomena F. McAndrew has 3 publications on record
Dmand AI links 3 papers to Dr. McAndrew, published from 2020 to 2024. 2020 was the busiest year, with 2. Dr. McAndrew's most frequent co-authors are Heather Lynn McArthur, MD, David M.j. Hoffman, MD and Karen Anne Autio, MD.
Dr. McAndrew's most frequent co-authors
- Heather Lynn McArthur, MD3 shared papers
- David M.j. Hoffman, MD2 shared papers
- Karen Anne Autio, MD1 shared paper
Recent publications by Dr. McAndrew
See who Dr. McAndrew researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. McAndrew works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Philomena F. McAndrew has worked on 5 clinical trials
Dmand AI links Dr. McAndrew to 5 clinical trials, 2 of them phase 1/2 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Brain Neoplasms.
Clinical trials with Dr. McAndrew by phase
- NonePhase 1: no trials
- 2Phase 1/2: 2 trials
- 2Phase 2: 2 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Trials with no phase (devices, behavioral studies) are left out.
Conditions in Dr. McAndrew's trials
- Breast Neoplasms
- Breast Diseases
- Brain Neoplasms
- Pathologic Complete Response
- Triple Negative Breast Neoplasms
Investigators on the most trials with Dr. McAndrew
- Dorothy J. Park, MD4 shared trials
- Reva Kakkar Basho, MD3 shared trials
- Heather Lynn McArthur, MD3 shared trials
Recent clinical trials with Dr. McAndrew
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy (opens in a new tab)
Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic (opens in a new tab)
Breast Cancer Study of Preoperative Pembrolizumab + Radiation (opens in a new tab)
Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Philomena F. McAndrew received $1,901 in industry payments from 2016 to 2025
CMS Open Payments shows 34 general payments to Dr. McAndrew from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 60% of the total. Stemline Therapeutics Inc. paid the most, $1,150.
General payments to Dr. McAndrew by program year, 2016 to 2025
General payments to Dr. McAndrew by kind, 2016 to 2025
- Consulting fees$1,15060%
- Food and beverage$54028%
- Education$21111%
Companies that paid Dr. McAndrew the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Philomena F. McAndrew has 5 awards and honors on record
Dmand AI lists 5 awards for Dr. McAndrew, most recently CMS Stage 1 EHR in 2013.
Awards and honors for Dr. McAndrew
- 2013
- CMS Stage 1 EHR
- Top Doctors:LA Area
- 2012
- Top Doctors:Southern California
- Undated
- Checkbook Top Doc
- Super Doc
Source: Dmand AI Professional Profile Data
Dr. Philomena F. McAndrew graduated from Perelman School of Medicine - Philadelphia
Dr. McAndrew graduated from Perelman School of Medicine - Philadelphia in 1978.
- Medical school
- Board certified in hematology
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Philomena F. McAndrew accepts plans from 7 insurance carriers
Dr. McAndrew is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.
- Aetna
- Blue Cross Blue Shield of Michigan
- Elevance
- Blue Cross Blue Shield of Massachusetts
- HCSC
- Regence Health Plans
- CMS Medicare
Plan types Dr. McAndrew accepts, by number of carriers
- Medicare7
- PPO6
- POS3
- EPO2
- HMO2
Source: Dmand AI Insurance Network Data
Sources for Dr. Philomena F. McAndrew's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Philomena F. McAndrew
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Philomena F. McAndrew's NPI number?
Dr. Philomena F. McAndrew's NPI number is 1104822600. It was assigned on June 21, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Philomena F. McAndrew?
Dr. Philomena F. McAndrew is a hematologist and oncologist in Beverly Hills, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Philomena F. McAndrew practice?
Dr. McAndrew practices at 9090 Wilshire Blvd, Beverly Hills, CA 90211. Dr. McAndrew's primary practice is Cedars-Sinai Tower Hematology and Oncology (Tho) - HOPD in Beverly Hills, California. Dmand AI also links Dr. McAndrew to 3 hospitals and 1 group practice or clinic.
What is Dr. Philomena F. McAndrew's medical license number?
Dr. McAndrew holds California license G47403, one of the licenses on file in 2 states.
Which states has Dr. Philomena F. McAndrew been licensed in?
Dmand AI has state licenses on file for Dr. McAndrew in California (1982 to 2026) and Pennsylvania (1980 to 1990).
Which hospitals is Dr. Philomena F. McAndrew affiliated with?
Dr. McAndrew is affiliated with Ronald Reagan UCLA Medical Center. Dmand AI links Dr. McAndrew to 3 more hospitals.
What medical group is Dr. Philomena F. McAndrew part of?
Dr. McAndrew is linked to Cedars-Sinai Medical Group.
Does Dr. Philomena F. McAndrew accept Medicare?
Yes. CMS data shows Dr. McAndrew billed Medicare for 6,746 services in 2024, and Dr. McAndrew accepts Medicare assignment.
Does Dr. Philomena F. McAndrew offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. McAndrew as offering telehealth services.
What is Dr. Philomena F. McAndrew's MIPS score?
Dr. McAndrew's MIPS final score for performance year 2024 is 89 out of 100, reported as part of a group.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Philomena F. McAndrew see?
CMS counts 703 Medicare patients who saw Dr. McAndrew in 2024, with an average age of 75.
Is Dr. Philomena F. McAndrew board certified?
Yes. Dr. McAndrew is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Philomena F. McAndrew bill to Medicare?
In 2024, Dr. McAndrew's most billed Medicare services were injected or infused drug (J9395), office visit, established patient (99214) and surgery: heart and blood vessels (36415).
Where did Dr. Philomena F. McAndrew go to medical school?
Dr. McAndrew graduated from Perelman School of Medicine - Philadelphia in 1978.
What drugs does Dr. Philomena F. McAndrew prescribe most?
In 2024 Medicare Part D data, Dr. McAndrew's most prescribed drugs by claims were Anastrozole, Exemestane and Letrozole.
Has Dr. Philomena F. McAndrew received payments from drug or device companies?
CMS Open Payments shows $1,901 in general payments to Dr. McAndrew from 8 companies from 2016 to 2025. The largest total came from Stemline Therapeutics Inc.
How long has Dr. Philomena F. McAndrew been practicing?
Dr. McAndrew graduated from medical school in 1978, 48 years ago.
Does Dr. Philomena F. McAndrew do research?
Dmand AI links 3 publications to Dr. McAndrew, published from 2020 to 2024. Dr. McAndrew has worked on 5 clinical trials.
Who does Dr. Philomena F. McAndrew publish with?
Dr. McAndrew's most frequent co-authors are Heather Lynn McArthur, MD (3 shared papers), David M.j. Hoffman, MD (2 shared papers) and Karen Anne Autio, MD (1 shared paper).
What insurance does Dr. Philomena F. McAndrew accept?
Dr. McAndrew is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card